This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hanin, L G Articles by Yakovlev, A Y Search for Related Content PubMed PubMed Citation Articles by Hanin, L G Articles by Yakovlev, A Y Pubmed/NCBI databases Medline Plus Health Information Prostate Cancer Social Bookmarking                         What's this?

Multivariate distributions of clinical covariates at the time of cancer detection

Department of Mathematics, Idaho State University, Pocatello, ID, USA, hanin{at}isu.edu

A Y Yakovlev

Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA

Many screening trials conducted in the past have generated a wealth of interesting data. These data represent an invaluable source of information for furthering our knowledge about the natural history of the disease. The traditional approach to modeling cancer screening tends to describe the process of tumor development in only one dimension, that is, the time natural history. A broader methodological idea is to construct a stochastic model of cancer development and detection that yields the multivariate distribution of observable variables at the time of diagnosis. By focusing on such multivariate observations, rather than just on the age of patients at diagnosis, this idea seeks to invoke an additional source of information (available only at the time of detection) in order to improve an estimation of unobservable quantitative parameters of cancer latency. In this article, we discuss modeling techniques that make the above-mentioned problems approachable. A special focus is placed on analytical tools for deriving joint distributions of clinical covariates at the time of cancer detection under an arbitrary screening protocol. In addition, some future research avenues and public health implications of the proposed approach are discussed.

Statistical Methods in Medical Research, Vol. 13, No. 6, 457-489 (2004)
DOI: 10.1191/0962280204sm378ra


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. G. Hanin, A. Miller, A. V. Zorin, and A. Y. Yakovlev Chapter 10: The University of Rochester Model of Breast Cancer Detection and Survival J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 66 - 78. [Abstract] [Full Text] [PDF]